Defining the Role of the Pharmacist in the Management of Von Willebrand Disease: Improving Patient Outcomes

Defining the Role of the Pharmacist in the Management of Von Willebrand Disease: Improving Patient Outcomes is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians and will be held from Sep 29, 2017 - Sep 29, 2019.

Credits: 2.0 hours (0.20 ceu)

Target Audience:
This accredited activity has been designed for pharmacists.

Goal:
To inform and educate pharmacists about von Willebrand disease, including the appropriate diagnosis and management of the disease.

Learning Objectives:
Upon completion of this activity, participants should be better able to:
• Describe the etiology of inherited and acquired von Willebrand disease (VWD)
• Explain the epidemiology of VWD, including the prevalence, distribution, and disease types
• List the various clinical and laboratory approaches to confirming a diagnosis of VWD
• Select an appropriate therapeutic approach for a patient with VWD
• Describe the appropriate indications, dosage, and safety concerns associated with recombinant von Willebrand factor

Additional details will be posted as soon as they are available.